FLCCC and WCH Publish Groundbreaking Peer-Reviewed Paper on Spike Protein Treatment

FLCCC, in partnership with the World Council for Health, has authored a groundbreaking paper exploring autophagy in treating SARS-CoV-2 spike protein-related pathology.

The Frontline Covid-19 Critical Care Alliance (FLCCC), in partnership with the World Council for Health (WCH), has recently authored a groundbreaking paper that has been published in the peer-reviewed journal Endocrine and Metabolic Science. The paper, titled ‘Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology’ is a comprehensive review of the modulation of autophagy to treat spike protein-related diseases and is authored by the FLCCC’s own Dr Paul Marik and Dr Yusuf Saleeby, and Matthew Halma of the World Council for Health.

Exposure to spike protein has been found to induce mitochondrial damage and altered metabolism and can downregulate autophagy. This is troublesome because autophagy is one process by which our bodies can clear out proteins, both of endogenous and exogenous origin.

Autophagy is your body's recycling system for cells

Our cells, the basic building blocks of every organ and tissue in our bodies, can stop working and break down over time. Instead of letting them stay inside, clutter up, and slow down otherwise healthy cells, autophagy reuses these damaged and old cell parts.

In short, autophagy causes a cell to become a recycling center by reusing whatever bits and pieces of old and damaged cells that it can, and tossing the bits it doesn't need.

Treating spike protein diseases

Our paper develops the therapeutic use of autophagy in treating spike protein diseases and is aimed at practitioners so that they better understand how autophagy can be used therapeutically, and how autophagy can be induced using fasting and other adjunctive strategies. See the paper’s abstract below:

Fasting, a practice with historical roots in various cultures, has recently garnered significant interest in the field of medicine. In this article, we delve into the mechanisms underlying fasting-induced autophagy and its therapeutic applications for spike protein associated pathology. We explore the therapeutic potential of fasting on spike protein-related pathology and the role of interventions to upregulate autophagy, including compounds like spermidine, resveratrol, rapamycin, and metformin. In conclusion, fasting, coupled with an understanding of its nuances, holds promise as a therapeutic intervention for SARS-CoV-2 spike protein related diseases; with broad implications for human health. This review presents the therapeutic possibility of using autophagy to treat spike protein related diseases, and details the interventions to deploy this therapeutic modality.

Present clinical trials on treating vaccine injury are limited, and most are focused on the (often misdiagnosed) condition of Long Covid. A great need exists to treat large numbers of vaccine-injured individuals. We are not presenting autophagy as a panacea, but it should be an arrow in each medical practitioner’s quiver.

Autophagy is not only useful for post-vaccination syndrome, but can also be used in the treatment of metabolic disease, cancer, and Alzheimer’s disease. 

This groundbreaking paper brings hope to those suffering from vaccine injury as well as practitioners looking to effectively treat their patients from this often puzzling disease. We are grateful for the support of our donors, which allows us to do this important work. Truly, this would not be possible without your support. You may support independent and solutions-focused research by donating to the Frontline Covid-19 Critical Care Alliance or to the World Council for Health. 

---

If you find value in this Substack and have the means, please consider making a contribution to support the World Council for Health. Thank you.